SYNB-1020

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameSYNB-1020
Drug Alias NameSYNB-1020
ClassificationBiologics
Mechanisms of ActionAmmonia scavengersMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsUrea Cycle Disorders, InbornLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSynlogic Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSynlogic Inc
Active IndicationsN/A
Inactive IndicationsUrea Cycle Disorders, InbornLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A